Sobi® (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant® (emapalumab) for ...
A randomized controlled trial of 5,018 women has found that a simple blood test, when paired with targeted interventions, can ...
Positive Interim Results of Phase 1a Single (SAD) and Multiple Ascending Dose (MAD) Trial Reinforce Potential Best-in-Class Potency Advantage ...
Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and ...
A new analysis of clinical trial data indicates that psilocybin, when administered alongside psychotherapy, may provide rapid ...
Products with THC reduced pain a little across multiple trials, but those that were mostly CBD didn't outperform placebos.
Get any of our free daily email newsletters — news headlines, opinion, e-edition, obituaries and more. SANTA ANA, Calif. (AP) — Lawyers for the Los Angeles Angels were discussing a possible settlement ...
The FDA is raising the bar for approval of CAR T-cell therapies in oncology. Under plans outlined by the FDA’s biologics chief Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to ...
is features writer with five years of experience covering the companies that shape technology and the people who use their tools. On Monday, several dozen members of the public are lined up outside ...
MultifocAL COntact Lenses for Myopia is a double-blind, contralateral eye, non-inferiority, randomised controlled trial (RCT) representing an alternative trial design to conventional, parallel group, ...